Smith & Nephew (SN) Competitors

Smith & Nephew (LON:SN) and Haleon (LON:HLN) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, community ranking, analyst recommendations, valuation and risk.

Do analysts rate SN or HLN?

Smith & Nephew currently has a consensus price target of GBX 7,840, indicating a potential upside of 610.47%. Haleon has a consensus price target of GBX 457, indicating a potential upside of 10.47%. Given Smith & Nephew's higher probable upside, equities analysts clearly believe Smith & Nephew is more favorable than Haleon.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smith & Nephew	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Haleon	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Is SN or HLN a better dividend stock?

Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 2.6%. Haleon pays an annual dividend of GBX 6 per share and has a dividend yield of 1.5%. Smith & Nephew pays out 104.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Haleon pays out 50.5% of its earnings in the form of a dividend.

Is SN or HLN more profitable?

Haleon has a net margin of 9.66% compared to Smith & Nephew's net margin of 5.41%. Haleon's return on equity of 6.54% beat Smith & Nephew's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Smith & Nephew	5.41%	5.85%	4.51%
Haleon	9.66%	6.54%	4.45%

Does the MarketBeat Community prefer SN or HLN?

Smith & Nephew received 548 more outperform votes than Haleon when rated by MarketBeat users. Likewise, 62.02% of users gave Smith & Nephew an outperform vote while only 31.58% of users gave Haleon an outperform vote.

Company	Underperform	Outperform
Smith & Nephew	Outperform Votes 560 62.02%	Underperform Votes 343 37.98%
Haleon	Outperform Votes 12 31.58%	Underperform Votes 26 68.42%

Does the media prefer SN or HLN?

In the previous week, Haleon had 5 more articles in the media than Smith & Nephew. MarketBeat recorded 6 mentions for Haleon and 1 mentions for Smith & Nephew. Haleon's average media sentiment score of 1.18 beat Smith & Nephew's score of -0.49 indicating that Haleon is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Smith & Nephew	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Haleon	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher valuation and earnings, SN or HLN?

Haleon has higher revenue and earnings than Smith & Nephew. Haleon is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smith & Nephew	£7.08B	1.71	£382.79M	£27.77	39.73
Haleon	£11.07B	3.37	£1.07B	£11.89	34.79

Do institutionals & insiders believe in SN or HLN?

62.2% of Smith & Nephew shares are held by institutional investors. Comparatively, 43.9% of Haleon shares are held by institutional investors. 0.2% of Smith & Nephew shares are held by insiders. Comparatively, 10.7% of Haleon shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Which has more risk & volatility, SN or HLN?

Smith & Nephew has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. Comparatively, Haleon has a beta of 0.19, indicating that its share price is 81% less volatile than the S&P 500.

Summary

Smith & Nephew beats Haleon on 10 of the 19 factors compared between the two stocks.